Literature DB >> 19590875

Dermatomyositis and cutaneous metastases from breast cancer: simultaneous development and parallel course.

Mario Vaccaro1, Francesco Borgia, Olga Barbuzza, Sebastiano Gangemi, Biagio Guarneri.   

Abstract

The association between dermatomyositis (DM) and various types of malignancies has been reported in several studies, with an estimated frequency of about 20-25%. Cancer may appear before the onset of DM, concurrently with DM or after its onset. In the present report, the occurrence of typical DM in concomitance with development of skin metastases from previously treated breast cancer is described, suggesting the role of DM as paraneoplastic marker not only in association with the primary tumor but also in case of cutaneous involvement by cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19590875     DOI: 10.1007/s00296-009-1026-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Relation between dermatomyositis and polymyositis and cancer.

Authors:  J P Callen
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

2.  Dermatomyositis associated with IgG myeloma.

Authors:  F Borgia; M Vaccaró; F Guarneri; S P Cannavó; B Guarneri
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

3.  Improvement in dermatomyositis rash associated with the use of antiestrogen medication.

Authors:  Danya Sereda; Victoria P Werth
Journal:  Arch Dermatol       Date:  2006-01

Review 4.  Cancer and myositis: new insights into an old association.

Authors:  Stuart M Levine
Journal:  Curr Opin Rheumatol       Date:  2006-11       Impact factor: 5.006

5.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 6.  Dermatomyositis.

Authors:  Jeffrey P Callen; Robert L Wortmann
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

7.  Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies.

Authors:  A Parodi; M Caproni; A V Marzano; C De Simone; M La Placa; P Quaglino; C Veller Fornasa; C Zane; M Vaccaro; M Papini; P Fabbri; A Rebora
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

8.  Cancer-associated myositis: clinical features and prognostic signs.

Authors:  Andrea Ponyi; Tamás Constantin; Miklós Garami; Csilla András; Béla Tállai; Andrea Váncsa; Lajos Gergely; Katalin Dankó
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

9.  A pilot trial of rituximab in the treatment of patients with dermatomyositis.

Authors:  Lorinda Chung; Mark C Genovese; David F Fiorentino
Journal:  Arch Dermatol       Date:  2007-06

10.  Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells.

Authors:  Giuseppe Carruba; Pietro D'Agostino; Monica Miele; Maurizio Calabrò; Caterina Barbera; Gloria Di Bella; Salvatore Milano; Viviana Ferlazzo; Rosalba Caruso; Marzia La Rosa; Letizia Cocciadiferro; Ildegarda Campisi; Luigi Castagnetta; Enrico Cillari
Journal:  J Cell Biochem       Date:  2003-09-01       Impact factor: 4.429

View more
  2 in total

1.  Breast cancer and dermatomyositis: a case study and literature review.

Authors:  E Hendren; O Vinik; H Faragalla; R Haq
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  Dermatosis as the Initial Manifestation of Malignant Breast Tumors: Retrospective Analysis of 4 Cases.

Authors:  Ying-Jie Song; Yun-Fei Wu; Tao Fan
Journal:  Breast Care (Basel)       Date:  2010-06-16       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.